Related Experiment Video
Updated: Feb 9, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.2K
Hydroxychloroquine: An old drug with new relevance
Eugen Alexander Shippey1, Vanya D Wagler2, Angelique N Collamer3
1Resident, Department of Internal Medicine, William Beaumont Army Medical Center, El Paso, TX, USA. eugen.shippey@gmail.com.
Cleveland Clinic Journal of Medicine
|June 9, 2018
Summary
Hydroxychloroquine is an immunomodulatory drug with a long history of treating malaria and autoimmune conditions. Updated guidelines address toxicity concerns, supporting its continued use and exploration of new therapeutic benefits.
Area of Science:
- Pharmacology
- Immunology
- Rheumatology
Background:
- Hydroxychloroquine has been a cornerstone therapy for over 60 years.
- It is utilized for managing malaria and autoimmune diseases like systemic lupus erythematosus and inflammatory arthritis.
- Emerging research continues to uncover novel applications and advantages of this drug.
Observation:
- The drug exhibits immunomodulatory properties, influencing the immune system's response.
- Long-term clinical use has established its efficacy in specific autoimmune conditions.
- Potential for expanded therapeutic indications is an active area of investigation.
Findings:
- Established efficacy in treating malaria and autoimmune diseases.
- Ongoing research suggests potential for new benefits and applications.
- Updated prescribing recommendations aim to mitigate toxicity risks.
Implications:
- The established safety profile, with updated recommendations, supports continued hydroxychloroquine use.
- Further research may broaden the clinical utility of hydroxychloroquine.
- This highlights the enduring relevance of hydroxychloroquine in clinical practice and research.
Related Concept Videos
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
222
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
222
01:25Pharmacokinetics: Drug–Drug Interactions
454
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
454
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
162
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
162
01:26FDA Approved Drugs: Changes to Approved Drugs
273
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
273
01:27Factors Influencing Drug Absorption: Drug Dissolution
1.2K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.2K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
488
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
488